Kaléo Announces Authorised Generic Evzio At A Fraction Of The Cost

Politicians and the public admonished Kaléo for pricing its opioid overdose revival agent at more than US$4,000 per unit; now the originator says an authorized generic version, costing only US$178, will hit shelves midway through next year.